Medicine guide
Infanrix Penta
·
- Prescription status not stated
- Antibiotics, antivirals and antifungals taken into the body
- Made by
- GlaxoSmithKline Biologicals S.A.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Infanrix Penta is indicated for primary and booster vaccination of infants against diphtheria, tetanus, pertussis, hepatitis B and poliomyelitis.
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | GlaxoSmithKline Biologicals S.A. |
|---|---|
| Active substance | Diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (inactivated) (IPV) vaccine (adsorbed) |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Classification | J07CA12 · Antibiotics, antivirals and antifungals taken into the body |
| Authorised on | 2000-10-23 |
| Last updated by the regulator | 2013-08-23 |
| EMA product number | EMEA/H/C/000295 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).